Stockreport

Histogen Announces Update for its HST-002 Dermal Filler Program

Histogen Inc.  (HSTO) 
PDF HST-002 Designated as Drug-Biologic-Device Combination Product HST-001 1b/2a Trial for Androgenic Alopecia in Men on Track for Top Line Data Results in 4Q20 HST-003 I [Read more]